Elevated plasma levels of S-100b protein in schizophrenic patients

Biological Psychiatry

Volumn 45, Issue 11, 1999, Pages 1508-1511

  Wiesmann, Martin ^a   Wandinger, Klaus P ^b   Missler, Ulrich ^a   Eckhoff, Dörte ^b   Rothermundt, Matthias ^b   Arolt, Volker ^b   Kirchner, Holger ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Biological markers; Cerebrospinal fluid proteins; S 100 protein; Schizophrenia

Indexed keywords

PROTEIN S 100;

ADULT; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUOROMETRY; HUMAN; MALE; NERVE CELL LESION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; SCHIZOPHRENIA;

ADULT; BIOLOGICAL MARKERS; BRAIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE GROWTH FACTORS; S100 PROTEINS; SCHIZOPHRENIA;

EID: 0032881853     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00217-0     Document Type: Article

References (24)

1. Axelsson R., Martensson E., Alling C. Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis. Br J Psychiatry. 141:1982;273-281.
2. Buer J., Probst M., Franzke A., Duensing S., Haindl J., Volkenandt M., et al. Elevated serum levels of S100 and survival in metastatic malignant melanoma. Br J Cancer. 75:1997;1373-1376.
3. Donato R. Perspectives in S-100 protein biology. Cell Calcium. 12:1991;713-726.
4. Fanó G., Biocca S., Fulle S., Mariggió M.A., Belia S., Calissano P. The S100 A protein family in search of a function . Prog Neurobiol. 46:1995;71-82.
5. Ganguli R., Brar J.S., Chengappa K.N.R., Yang Z.W., Nimgaonkar V.L., Rabin B.S. Autoimmunity in schizophrenia. Ann Med. 25:1993;489-496.
6. Green A.J.E., Keir G., Thompson E.J. A specific and sensitive ELISA for measuring S-1006 in cerebrospinal fluid. J Immunol Methods. 205:1997;35-41.
7. Henneberg A.E., Ruffert S., Henneberg H.J., Kornhuber H.H. Antibodies to brain tissue in sera of schizophrenic patients - Preliminary findings. Eur Arch Psychiatry Clin Neurosci. 242:1993;314-317.
8. Ingebrigtsen T., Romner B. Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury. J Neurosurg. 85:1996;945-948.
9. Ingebrigtsen T., Romner B., Kongstad P., Langbakk B. Increased serum concentrations of protein S-100 after minor head injury A biochemical serum marker with prognostic value? J Neurol Neurosurg Psychiatry. 59:1995;103-104.
10. Kirch D.G. Infection and autoimmunity as etiologic factors in schizophrenia A review and reappraisal . Schizophr Bull. 19:1993;355-370.
11. Lamers K.J.B., van Engelen B.G.M., Gabreels F.J.M., Hommes O.R., Borm G.F., Wevers R.A. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders. Acta Neurol Scand. 92:1995;247-251.
12. Lim K.O., Harris D., Beal M., Hoff A.L., Minn K., Csernansky J.G., et al. Gray matter deficits in young onset schizophrenia are independent of age of onset. Biol Psychiatry. 40:1996;4-13.
13. McAllister C.G., van Kammen D.P., Rehn T.J., Miller A.L., Gurklis J., Kelley M.E., et al. Increases in CSF levels of interleukin-2 in schizophrenia Effects of recurrence of psychosis and medication status . Am J Psychiatry. 152:1995;1291-1297.
14. Missler U., Wandinger K.P., Wiesmann M., Kaps M., Wessel K. Acute exacerbation of multiple sclerosis increases plasma levels of S-100 protein. Acta Neurol Scand. 96:1997;142-144.
15. Missler U., Wiesmann M., Friedrich C., Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 28:1997;1956-1960.
16. Pearlson G.D., Marsh L. Magnetic resonance imaging in psychiatry. Oldham J.M., Riba M.B., Tasman A. Annual Review of Psychiatry. vol 12:1993;347-382 American Psychiatric Press, Washington, DC.
17. Persson L., Hårdemark H.G., Gustafsson J., Rundström G., Mendel-Hartvig I., Esscher T., et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum Markers of cell damage in human central nervous system . Stroke. 18:1987;911-918.
18. Rapaport M.H., Lohr J.B. Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia. Acta Psychiatr Scand. 90:1994;311-315.
19. Rothermundt M., Arolt V., Weitzsch C., Eckhoff D., Kirchner H. Production of cytokines in acute schizophrenic psychosis. Biol Psychiatry. 40:1996;1294-1297.
20. Strand T., Alling C., Karlsson B., Karlsson I., Winblad B. Brain and plasma proteins in spinal fluid as markers for brain damage and severity of stroke. Stroke. 15:1984;138-144.
21. Tamminga C.A., Thaker G.K., Buchanan R., Kirkpatrick B., Alphs L.D., Chase T.N., et al. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry. 49:1992;522-530.
22. Wiesmann M., Missler U., Hagenström H., Gottmann D. S-100 protein plasma levels after subarachnoid haemorrhage. Acta Neurochir (Wien). 139:1997;1155-1160.
23. Woertgen C., Rothoerl R.D., Holzschuh M., Metz C., Brawanski A. Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir (Wien). 139:1997;1161-1165.
24. Zimmer D.B., Cornwall E.H., Landar A., Song W. The S100 protein family History, function, and expression . Brain Res Bull. 37:1995;417-429.